Fasken Martineau DuMoulin LLP advised Debiopharm Innovation Fund in the transaction. Altis Labs Inc. announced the closing of its C$7.9 million ($6 Million) seed funding round co-led by...
You must be a Standard 1 Year member to access this content.
Jones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital on the deal. Iktos, a Paris, France-based company specializing in artificial intelligence for new drug...
You must be a Standard 1 Year member to access this content.
Debiopharm Innovation Fund was represented by EBN&Co. Debiopharm Innovation Fund led a USD 6 million Series Seed financing round in YonaLink Ltd. YonaLink Ltd. develops a...
You must be a Standard 1 Year member to access this content.
